Crystal structure of an enzyme displaying both inositol-polyphosphate-1-phosphatase and 3′-phosphoadenosine-5′-phosphate phosphatase activities: a novel target of lithium therapy
- 25 January 2002
- journal article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 315 (4) , 677-685
- https://doi.org/10.1006/jmbi.2001.5271
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Testosterone-Induced Growth of S115 Mouse Mammary Tumor Cells Is Dependent on Heparan SulfateExperimental Cell Research, 2001
- Tyrosine Sulfation of the Amino Terminus of CCR5 Facilitates HIV-1 EntryCell, 1999
- A member of a family of sulfate-activating enzymes causes murine brachymorphismProceedings of the National Academy of Sciences, 1998
- Lithium toxicity in yeast is due to the inhibition of RNA processing enzymesThe EMBO Journal, 1997
- The importance of 3‘‐phosphoadenosine 5‘‐phosphosulfate (PAPS) in the regulation of sulfationThe FASEB Journal, 1997
- Identification and Partial Purification of PAPS TranslocaseBiochemistry, 1996
- Kinetics of PAPS Translocase: Evidence for an Antiport MechanismBiochemistry, 1996
- Sulfation pharmacogenetics in humansChemico-Biological Interactions, 1994
- Molecular enzymology of human liver cytosolic sulfotransferasesTrends in Pharmacological Sciences, 1991
- Inhibition of M and P Phenol Sulfotransferase by Analogues of 3′‐Phosphoadenosine‐5′‐PhosphosulfateJournal of Neurochemistry, 1987